56 related articles for article (PubMed ID: 23334858)
1. The G84E mutation in the HOXB13 gene is associated with an increased risk of prostate cancer in Poland.
Kluźniak W; Wokołorczyk D; Kashyap A; Jakubowska A; Gronwald J; Huzarski T; Byrski T; Dębniak T; Gołąb A; Gliniewicz B; Sikorski A; Switała J; Borkowski T; Borkowski A; Antczak A; Wojnar L; Przybyła J; Sosnowski M; Małkiewicz B; Zdrojowy R; Sikorska-Radek P; Matych J; Wilkosz J; Różański W; Kiś J; Bar K; Bryniarski P; Paradysz A; Jersak K; Niemirowicz J; Słupski P; Jarzemski P; Skrzypczyk M; Dobruch J; Domagała P; Akbari MR; Lubiński J; Narod SA; Cybulski C;
Prostate; 2013 Apr; 73(5):542-8. PubMed ID: 23334858
[TBL] [Abstract][Full Text] [Related]
2. Association between germline homeobox B13 (HOXB13) G84E allele and prostate cancer susceptibility: a meta-analysis and trial sequential analysis.
Zhang J; Xiao L; Qin Z; Xu A; Zhao K; Liang C; Miao C; Zhu J; Chen W; Hua Y; Liu Y; Zhang C; Yu Y; Su S; Wang Z
Oncotarget; 2016 Oct; 7(41):67101-67110. PubMed ID: 27626483
[TBL] [Abstract][Full Text] [Related]
3. HOXB13 G84E-related familial prostate cancers: a clinical, histologic, and molecular survey.
Smith SC; Palanisamy N; Zuhlke KA; Johnson AM; Siddiqui J; Chinnaiyan AM; Kunju LP; Cooney KA; Tomlins SA
Am J Surg Pathol; 2014 May; 38(5):615-26. PubMed ID: 24722062
[TBL] [Abstract][Full Text] [Related]
4. Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk.
Liu J; Prager-van der Smissen WJC; Collée JM; Bolla MK; Wang Q; Michailidou K; Dennis J; Ahearn TU; Aittomäki K; Ambrosone CB; Andrulis IL; Anton-Culver H; Antonenkova NN; Arndt V; Arnold N; Aronson KJ; Augustinsson A; Auvinen P; Becher H; Beckmann MW; Behrens S; Bermisheva M; Bernstein L; Bogdanova NV; Bogdanova-Markov N; Bojesen SE; Brauch H; Brenner H; Briceno I; Brucker SY; Brüning T; Burwinkel B; Cai Q; Cai H; Campa D; Canzian F; Castelao JE; Chang-Claude J; Chanock SJ; Choi JY; Christiaens M; Clarke CL; ; Couch FJ; Czene K; Daly MB; Devilee P; Dos-Santos-Silva I; Dwek M; Eccles DM; Eliassen AH; Fasching PA; Figueroa J; Flyger H; Fritschi L; Gago-Dominguez M; Gapstur SM; García-Closas M; García-Sáenz JA; Gaudet MM; Giles GG; Goldberg MS; Goldgar DE; Guénel P; Haiman CA; Håkansson N; Hall P; Harrington PA; Hart SN; Hartman M; Hillemanns P; Hopper JL; Hou MF; Hunter DJ; Huo D; ; Ito H; Iwasaki M; Jakimovska M; Jakubowska A; John EM; Kaaks R; Kang D; Keeman R; Khusnutdinova E; Kim SW; Kraft P; Kristensen VN; Kurian AW; Le Marchand L; Li J; Lindblom A; Lophatananon A; Luben RN; Lubiński J; Mannermaa A; Manoochehri M; Manoukian S; Margolin S; Mariapun S; Matsuo K; Maurer T; Mavroudis D; Meindl A; Menon U; Milne RL; Muir K; Mulligan AM; Neuhausen SL; Nevanlinna H; Offit K; Olopade OI; Olson JE; Olsson H; Orr N; Park SK; Peterlongo P; Peto J; Plaseska-Karanfilska D; Presneau N; Rack B; Rau-Murthy R; Rennert G; Rennert HS; Rhenius V; Romero A; Ruebner M; Saloustros E; Schmutzler RK; Schneeweiss A; Scott C; Shah M; Shen CY; Shu XO; Simard J; Sohn C; Southey MC; Spinelli JJ; Tamimi RM; Tapper WJ; Teo SH; Terry MB; Torres D; Truong T; Untch M; Vachon CM; van Asperen CJ; Wolk A; Yamaji T; Zheng W; Ziogas A; Ziv E; Torres-Mejía G; Dörk T; Swerdlow AJ; Hamann U; Schmidt MK; Dunning AM; Pharoah PDP; Easton DF; Hooning MJ; Martens JWM; Hollestelle A
Sci Rep; 2020 Jun; 10(1):9688. PubMed ID: 32546843
[TBL] [Abstract][Full Text] [Related]
5. Inherited Predisposition to Prostate Cancer: From Gene Discovery to Clinical Impact.
Cooney KA
Trans Am Clin Climatol Assoc; 2017; 128():14-23. PubMed ID: 28790484
[TBL] [Abstract][Full Text] [Related]
6. HOXB13 and other high penetrant genes for prostate cancer.
Pilie PG; Giri VN; Cooney KA
Asian J Androl; 2016; 18(4):530-2. PubMed ID: 27034017
[TBL] [Abstract][Full Text] [Related]
7. Variants in ATRIP are associated with breast cancer susceptibility in the Polish population and UK Biobank.
Cybulski C; Zamani N; Kluźniak W; Milano L; Wokołorczyk D; Stempa K; Rudnicka H; Zhang S; Zadeh M; Huzarski T; Jakubowska A; Dębniak T; Lener M; Szwiec M; Domagała P; Samani AA; Narod S; Gronwald J; Masson JY; Lubiński J; Akbari MR
Am J Hum Genet; 2023 Apr; 110(4):648-662. PubMed ID: 36977412
[TBL] [Abstract][Full Text] [Related]
8. An appraisal of genetic testing for prostate cancer susceptibility.
Finch A; Clark R; Vesprini D; Lorentz J; Kim RH; Thain E; Fleshner N; Akbari MR; Cybulski C; Narod SA
NPJ Precis Oncol; 2022 Jun; 6(1):43. PubMed ID: 35732815
[TBL] [Abstract][Full Text] [Related]
9. Clinical Significance of Gene Mutations and Polymorphic Variants and their Association with Prostate Cancer Risk in Polish Men.
Heise M; Jarzemski P; Nowak D; Bąk A; Junkiert-Czarnecka A; Pilarska-Deltow M; Borysiak M; Pilarska B; Haus O
Cancer Control; 2022; 29():10732748211062342. PubMed ID: 35638715
[No Abstract] [Full Text] [Related]
10. Germline HOXB13 mutation p.G84E do not confer an increased bladder or kidney cancer risk in polish population.
Złowocka-Perłowska E; Tołoczko-Grabarek A; Lubiński J
Hered Cancer Clin Pract; 2022 Jan; 20(1):1. PubMed ID: 34983599
[TBL] [Abstract][Full Text] [Related]
11. Homeobox B13 G84E Mutation and Prostate Cancer Risk.
Nyberg T; Govindasami K; Leslie G; Dadaev T; Bancroft E; Ni Raghallaigh H; Brook MN; Hussain N; Keating D; Lee A; McMahon R; Morgan A; Mullen A; Osborne A; Rageevakumar R; ; Kote-Jarai Z; Eeles R; Antoniou AC
Eur Urol; 2019 May; 75(5):834-845. PubMed ID: 30527799
[TBL] [Abstract][Full Text] [Related]
12. Targeting the BRD4-HOXB13 Coregulated Transcriptional Networks with Bromodomain-Kinase Inhibitors to Suppress Metastatic Castration-Resistant Prostate Cancer.
Nerlakanti N; Yao J; Nguyen DT; Patel AK; Eroshkin AM; Lawrence HR; Ayaz M; Kuenzi BM; Agarwal N; Chen Y; Gunawan S; Karim RM; Berndt N; Puskas J; Magliocco AM; Coppola D; Dhillon J; Zhang J; Shymalagovindarajan S; Rix U; Kim Y; Perera R; Lawrence NJ; Schonbrunn E; Mahajan K
Mol Cancer Ther; 2018 Dec; 17(12):2796-2810. PubMed ID: 30242092
[TBL] [Abstract][Full Text] [Related]
13. Association of zinc level and polymorphism in MMP-7 gene with prostate cancer in Polish population.
Białkowska K; Marciniak W; Muszyńska M; Baszuk P; Gupta S; Jaworska-Bieniek K; Sukiennicki G; Durda K; Gromowski T; Prajzendanc K; Cybulski C; Huzarski T; Gronwald J; Dębniak T; Scott RJ; Lubiński J; Jakubowska A
PLoS One; 2018; 13(7):e0201065. PubMed ID: 30036379
[TBL] [Abstract][Full Text] [Related]
14. Survival outcomes of locally advanced prostate cancer in patients aged < 50 years after local therapy in the contemporary US population.
Sheng W; Zhang H; Lu Y
Int Urol Nephrol; 2018 Aug; 50(8):1435-1444. PubMed ID: 29982959
[TBL] [Abstract][Full Text] [Related]
15. Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference 2017.
Giri VN; Knudsen KE; Kelly WK; Abida W; Andriole GL; Bangma CH; Bekelman JE; Benson MC; Blanco A; Burnett A; Catalona WJ; Cooney KA; Cooperberg M; Crawford DE; Den RB; Dicker AP; Eggener S; Fleshner N; Freedman ML; Hamdy FC; Hoffman-Censits J; Hurwitz MD; Hyatt C; Isaacs WB; Kane CJ; Kantoff P; Karnes RJ; Karsh LI; Klein EA; Lin DW; Loughlin KR; Lu-Yao G; Malkowicz SB; Mann MJ; Mark JR; McCue PA; Miner MM; Morgan T; Moul JW; Myers RE; Nielsen SM; Obeid E; Pavlovich CP; Peiper SC; Penson DF; Petrylak D; Pettaway CA; Pilarski R; Pinto PA; Poage W; Raj GV; Rebbeck TR; Robson ME; Rosenberg MT; Sandler H; Sartor O; Schaeffer E; Schwartz GF; Shahin MS; Shore ND; Shuch B; Soule HR; Tomlins SA; Trabulsi EJ; Uzzo R; Vander Griend DJ; Walsh PC; Weil CJ; Wender R; Gomella LG
J Clin Oncol; 2018 Feb; 36(4):414-424. PubMed ID: 29236593
[TBL] [Abstract][Full Text] [Related]
16. HOXB13 mutations and binding partners in prostate development and cancer: Function, clinical significance, and future directions.
Brechka H; Bhanvadia RR; VanOpstall C; Vander Griend DJ
Genes Dis; 2017 Jun; 4(2):75-87. PubMed ID: 28798948
[TBL] [Abstract][Full Text] [Related]
17. Computational Modeling of complete HOXB13 protein for predicting the functional effect of SNPs and the associated role in hereditary prostate cancer.
Chandrasekaran G; Hwang EC; Kang TW; Kwon DD; Park K; Lee JJ; Lakshmanan VK
Sci Rep; 2017 Mar; 7():43830. PubMed ID: 28272408
[TBL] [Abstract][Full Text] [Related]
18. Somatic molecular subtyping of prostate tumors from HOXB13 G84E carriers.
Lotan TL; Torres A; Zhang M; Tosoian JJ; Guedes LB; Fedor H; Hicks J; Ewing CM; Isaacs SD; Johng D; De Marzo AM; Isaacs WB
Oncotarget; 2017 Apr; 8(14):22772-22782. PubMed ID: 28186998
[TBL] [Abstract][Full Text] [Related]
19. Oncogenic mechanisms of
Cardoso M; Maia S; Paulo P; Teixeira MR
Oncoscience; 2016; 3(9-10):288-296. PubMed ID: 28050579
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
